Hester Biosciences

Hester Biosciences

HESTERBIO.NS
Ahmedabad, India· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

HESTERBIO.NS · Stock Price

INR 1,638.00-109.60 (-6.27%)
Market Cap: $148.2M

Historical price data

Market Cap: $148.2MFounded: 1985HQ: Ahmedabad, India

Overview

Hester Biosciences is a mission-driven animal health leader focused on enhancing livestock productivity and food security through affordable, high-quality vaccines and pharmaceuticals. Founded in 1987, it has scaled to become Asia's largest one-stop animal biological manufacturer, producing billions of doses annually from plants in India, Nepal, and Tanzania. Its strategy combines dominating core poultry and livestock vaccine markets in South Asia and Africa with a recent strategic diversification into human vaccines and diagnostic services to drive future growth.

Animal Health (Poultry)Animal Health (Livestock)Zoonotic Disease Prevention

Technology Platform

Mastery of established, scalable biological manufacturing processes, including fermentation for bacterial vaccines and cell culture technology for viral vaccines, optimized for high-volume, low-cost production in emerging markets.

Funding History

1
IPOUndisclosed

Opportunities

The company is poised to capitalize on massive macro trends including rising animal protein demand in Asia/Africa, government-led livestock vaccination programs, and the global focus on zoonotic disease prevention.
Its local manufacturing in Nepal and Tanzania provides a unique competitive edge in these high-growth, underserved regions.

Risk Factors

Key risks include execution challenges in its new human vaccine initiative, potential biosecurity events affecting livestock populations, intense competition in core markets pressuring margins, and regulatory/quality compliance risks across its global manufacturing footprint.

Competitive Landscape

Hester is the #2 player in India's poultry vaccine market, competing with Venkys and others, while also facing multinational animal health giants like Zoetis in broader markets. Its primary competitive advantages are unparalleled cost leadership from scaled manufacturing, a deep distribution network in rural areas, and products specifically tailored for emerging market conditions.